Dr. Koen Van Besien, MD
Claim this profileWeill Cornell Medical College
Studies Leukemia
Studies Lymphoma
15 reported clinical trials
23 drugs studied
Area of expertise
1Leukemia
CD19 positive
Philadelphia chromosome positive
Second relapse
2Lymphoma
CD19 positive
Philadelphia chromosome positive
CD5 positive
Affiliated Hospitals
Clinical Trials Koen Van Besien, MD is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab and rituximab plus chemotherapy or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
AIC100 CAR T Cells
for Thyroid Cancer
This trial tests a new treatment using modified immune cells to fight certain types of thyroid cancer that haven't responded to other treatments. The patient's own cells are changed in a lab to better target and kill cancer cells, then reintroduced into their body. This new method aims to improve the ability of the patient's immune system to find and destroy cancer cells.
Recruiting1 award Phase 110 criteria
More about Koen Van Besien, MD
Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Koen Van Besien, MD has experience with
- AgenT-797
- Orca-T
- Tabelecleucel
- Unlicensed Cryopreserved Cord Blood Units
- PBCAR0191
- Cyclophosphamide
Breakdown of trials Koen Van Besien, MD has run
Leukemia
Lymphoma
Tumors
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Koen Van Besien, MD specialize in?
Koen Van Besien, MD focuses on Leukemia and Lymphoma. In particular, much of their work with Leukemia has involved CD19 positive patients, or patients who are Philadelphia chromosome positive.
Is Koen Van Besien, MD currently recruiting for clinical trials?
Yes, Koen Van Besien, MD is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Koen Van Besien, MD has studied deeply?
Yes, Koen Van Besien, MD has studied treatments such as agenT-797, Orca-T, Tabelecleucel.
What is the best way to schedule an appointment with Koen Van Besien, MD?
Apply for one of the trials that Koen Van Besien, MD is conducting.
What is the office address of Koen Van Besien, MD?
The office of Koen Van Besien, MD is located at: Weill Cornell Medical College, New York, New York 10021 United States. This is the address for their practice at the Weill Cornell Medical College.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.